Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.
Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.
复制标题
趋同基因组研究确定了 GRIK2 和 NPAS2 与慢性疲劳综合征的关联。
DOI:
10.1159/000326692
复制
发表时间:
2011
影响因子:
3.2
通讯作者:
Rajeevan,MangalathuS
中科院分区:
文献类型:
--
作者:
Smith,AliciaK;Fang,Hong;Whistler,Toni;Unger,ElizabethR;Rajeevan,MangalathuS
Background:There is no consistent evidence of specific gene(s) or molecular pathways that contribute to the pathogenesis, therapeutic intervention or diagnosis of chronic fatigue syndrome (CFS). While multiple studies support a role for genetic variation in CFS, genome-wide efforts to identify associated loci remain unexplored. We employed a novel convergent functional genomics approach that incorporates the findings from single-nucleotide polymorphism (SNP) and mRNA expression studies to identify associations between CFS and novel candidate genes for further investigation.Methods:We evaluated 116,204 SNPs in 40 CFS and 40 nonfatigued control subjects along with mRNA expression of 20,160 genes in a subset of these subjects (35 CFS subjects and 27 controls) derived from a population-based study.Results:Sixty-five SNPs were nominally associated with CFS (p < 0.001), and 165 genes were differentially expressed (≧4-fold; p ≤ 0.05) in peripheral blood mononuclear cells of CFS subjects. Two genes, glutamate receptor, ionotropic, kinase 2(GRIK2)and neuronal PAS domain protein 2(NPAS2),were identified by both SNP and gene expression analyses. Subjects with the G allele of rs2247215(GRIK2)were more likely to have CFS (p = 0.0005), and CFS subjects showed decreasedGRIK2expression (10-fold; p = 0.015). Subjects with the T allele of rs356653(NPAS2)were more likely to have CFS (p = 0.0007), andNPAS2expression was increased (10-fold; p = 0.027) in those with CFS.Conclusion:Using an integrated genomic strategy, this study suggests a possible role for genes involved in glutamatergic neurotransmission and circadian rhythm in CFS and supports further study of novel candidate genes in independent populations of CFS subjects.